FDA drafts guidance on Type V DMFs for combination products
The FDA on Monday issued draft guidance detailing when a Type V drug master file (DMF) can be used to provide information about CDER …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
